Reset Pharma Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$11.1M
- Investors
-
9
Reset Pharma General Information
Description
Operator of a neuro-biotechnology therapies intended to improve mental health by resetting neural pathways associated with psychological trauma. The company offers psilocybin-inspired treatments and research-driven approaches, enabling patients with life-altering illnesses to address emotional distress and regain psychological well-being.
Contact Information
Website
www.resetpharma.comCorporate Office
- 98 Cuttermill Road
- Suite 466
- Great Neck, NY 11021
- United States
Corporate Office
- 98 Cuttermill Road
- Suite 466
- Great Neck, NY 11021
- United States
Reset Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 16-Feb-2022 | $11.1M | Completed | Product Development |
Reset Pharma Patents
Reset Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024263859-A1 | Psilocin or psilocybin for use in the treatment of demoralisation syndrome | Inactive | 22-Jun-2023 | ||
| GB-202207765-D0 | Administration of a psychedelic compound | Inactive | 26-May-2022 | ||
| GB-202207766-D0 | Administration of a psychedelic compound | Inactive | 26-May-2022 | ||
| GB-202207767-D0 | Administration of a psychedelic compound | Inactive | 26-May-2022 | ||
| US-20230364007-A1 | Administration of a psychedelic compound | Pending | 13-May-2022 | A61K9/0019 |
Reset Pharma Signals
Reset Pharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ayuh Ventures | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Iter Investments | Venture Capital | Minority | ||
| Merida Capital Holdings | Growth/Expansion | Minority | ||
| MSA Capital (Family Office) | Family Office | Minority |
Reset Pharma FAQs
-
When was Reset Pharma founded?
Reset Pharma was founded in 2020.
-
Where is Reset Pharma headquartered?
Reset Pharma is headquartered in Great Neck, NY.
-
What is the size of Reset Pharma?
Reset Pharma has 5 total employees.
-
What industry is Reset Pharma in?
Reset Pharma’s primary industry is Drug Discovery.
-
Is Reset Pharma a private or public company?
Reset Pharma is a Private company.
-
What is Reset Pharma’s current revenue?
The current revenue for Reset Pharma is .
-
How much funding has Reset Pharma raised over time?
Reset Pharma has raised $11.1M.
-
Who are Reset Pharma’s investors?
Ayuh Ventures, Gaingels, Iter Investments, Merida Capital Holdings, and MSA Capital (Family Office) are 5 of 9 investors who have invested in Reset Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process